Latest Regeneration Stories
FREDERICK, Md., April. 5, 2012 /PRNewswire/ -- BioElectronics Corporation. (OTC-PINK: BIEL), the maker of disposable, inexpensive drug-free topical pain and healing devices, today announced the publication of an article in the peer reviewed journal The Journal of Craniofacial Surgery - Differentiation of osteoprogenitor cells is induced by high-frequency pulsed electromagnetic fields. Teven CM, Greives M, Natale RB, Su Y, Luo Q, He BC, Shenaq D, He TC, Reid RR J Craniofac Surg. 2012...
(Ivanhoe Newswire) -- New research reveals new developments to reprogram scar tissue, that is a result from myocardial infarction (MI), into heart muscle cells. Scientists believe the new approach is a "game changer" with potential to revolutionise treatment of MI. "Our ultimate hope is that, during the acute period following MI, patients will be able to receive direct injections of factors that transform the existing fibroblast cells in the "scar" into new myocytes. The resulting...
The latest research developments to reprogram scar tissue resulting from myocardial infarction (MI) into viable heart muscle cells, were presented at the Frontiers in CardioVascular Biology (FCVB) 2012 meeting, held 30 March to 1 April at the South Kensington Campus of Imperial College in London. In a keynote lecture Dr Deepak Srivastava outlined his approach that has been described as a "game changer" with the potential to revolutionize treatment of MI. For the first time at the FCVB...
Medicine's recipe for keeping older people active and functioning in their homes and workplaces — and healing younger people injured in catastrophic accidents — may include "noodle gels" and other lab-made invisible filaments that resemble uncooked spaghetti with nanoscale dimensions, a scientist said here today at the 243rd National Meeting & Exposition of the American Chemical Society (ACS). The world's largest scientific society, ACS is meeting here this week with reports on more...
TAMPA, Fla., March 21, 2012 /PRNewswire/ -- Bioquark Inc., (www.bioquark.com) a biopharmaceutical company developing proprietary biological drugs for regeneration and repair of human organs and tissues, announced today that it has retained the services of JSBarkats PLLC to represent Bioquark in all aspects of the company's SEC compliance and securities legal work, as well as help with structuring future financing for the company. "We are pleased to be working with the seasoned group...
Research from a Kansas State University professor may make it easier to recover after spinal cord injury or to study neurological disorders. Mark Weiss, professor of anatomy and physiology, is researching genetic models for spinal cord injury or diseases such as Parkinson's disease. He is developing technology that can advance cellular therapy and regenerative medicine -- a type of research that can greatly improve animal and human health. "We're trying to build tools, trying to build...
WINSTON-SALEM, N.C., March 19, 2012 /PRNewswire/ -- Tengion, Inc. (NASDAQ: TNGN), a leader in regenerative medicine, today announced it will host a conference call and live audio webcast on Monday, March 26, 2012, at 5:00 p.m. EDT to provide a business update and discuss its fourth quarter 2011 financial results. To participate in the call, please dial 1-800-638-4930 (domestic) or 1-617-614-3944 (international) and reference access code 34844557. The conference call can be accessed...
Implications for treatment of birth defects, wounds, cancer The genetic pathway that regulates the way cells align themselves relative to each other has been found to act as a "stop sign" that signals organisms when to halt cell growth, according to new research published by biologists at the Center for Regenerative and Developmental Biology in Tufts University's School of Arts and Sciences. The research sheds light on one of the primary challenges to developing new ways to induce...
A research team has identified epigenetic signatures, markers on DNA that control transient changes in gene expression, within reprogrammed skin cells. These signatures can predict the expression of a wound-healing protein in reprogrammed skin cells or induced pluripotent stem cells (iPSCs), cells that take on embryonic stem cell properties. Understanding how the expression of the protein is controlled brings us one step closer to developing personalized tissue regeneration strategies using...
